Cornell researchers are exploring a new approach to reducing the spread of mosquito-borne viruses through seminal fluid proteins from male mosquitoes that disrupt the reproductive biology in females.
Cross-campus gathering will focus on the biggest challenges facing the world, and help determine a theme on which the university will focus in the 2019-2020 academic year.
A naturally produced chemical exacerbates infection by a common bacteria, rendering the infection significantly harder for the body to clear, according to new Cornell cross-campus research.
Cornellians gathered March 4 for talks on food ethics by Andrew Chignell, visiting associate professor of philosophy, and on small farms by Anu Rangarajan, director of the Cornell Small Farms Program.
A set of gene variants originating in Sub-Saharan West Africa may help explain why black women have worse breast cancer outcomes than white women, say researchers at Weill Cornell Medicine and NewYork-Presbyterian.
From studying labor law to understanding obesity, about undergraduate scholars shared their results at the Hunter R. Rawlings III Research Scholars Senior Expo and at CURBx, April 19.
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccine.
A newly discovered type of genetic mutation in cancer cells may provide clues about the disease's origins and offer new therapeutic targets, according to research from Weill Cornell Medicine and the New York Genome Center.